Abbott Laboratories recently received FDA clearance for Tendyne, its transcatheter mitral valve replacement system. The news comes on the heels of Edwards Lifesciences Corp. securing a CE mark for its ...

Edwards Lifesciences is projected to deliver steady profit and revenue growth through 2026. Click here to read more on EW ...

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.

This was the stock's fourth consecutive day of gains.

A Relative Strength Rating upgrade for Edwards Lifesciences shows improving technical performance. Will it continue?

St. Luke’s Heart and Vascular team became the first in the region to perform a transcatheter tricuspid valve replacement ...

Boston Scientific’s retreat from selling its ACURATE heart valves and halting FDA approval efforts created mild ripples in ...

Edwards Lifesciences (EW) stock and Medtronic (MDT) stock gain as Boston Scientific (BSX) halts sales of ACURATE heart valves ...

Investors responded positively to the news, boosting Edwards Lifesciences’ stock during the trading session. The company, which is a leading player in the heart valve market, may now face less ...

Edwards Lifesciences (NYSE:EW) saw its shares rise by 3% following news that competitor Boston Scientific (NYSE:BSX) is ...

This was the stock's second consecutive day of gains.